NASDAQ$ASTH

Astrana Health Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Reported strong second quarter results driven by organic growth and successful integration of Community Family Care acquisition.

Astrana Health reported strong second quarter results driven by continued organic growth in the Care Partners segment, the successful integration of the Community Family Care acquisition, and continued success in managing total cost of care. The company also entered Arizona and Hawai'i, partnered with Anthem Blue Cross and Elation Health, and agreed to acquire Collaborative Health Systems.

  • Strong second quarter results reflect progress, scale, and momentum at Astrana.
  • Revenue and adjusted EBITDA growth driven by organic growth in Care Partners segment.
  • Successful integration of the Community Family Care acquisition.
  • Entry into Arizona and Hawai'i, partnerships with Anthem Blue Cross and Elation Health, and agreement to acquire Collaborative Health Systems are anticipated to continue driving strong, sustainable, and profitable growth.

Headline financials

Total Revenue

$486M

Previous: $348M+39.6%
EPS (adj)

$0.40

Previous: $0.29+37.9%
Capital Expenditures

-$3.21M

Previous: -$17.4M+81.5%
Free Cash Flow

$16M

Previous: -$4.2M+480.4%
Net Income

$19.2M

Previous: $13.2M+45.6%
Operating Income

$30.1M

Previous: $27M+11.2%
Gross Profit

-$420M

Previous: -$297M-41.6%
Cash & Equivalents

$325M

Previous: $294M+10.7%
Total Assets

$1.25B

Previous: $1.03B+21.9%
Stock-Based Comp

$7.39M

Previous: $4.21M+75.4%

Revenue & EPS history

Astrana Health · Revenue · Quarterly

$486M

Q2 2024+39.6%vs Q2 2023
Beat estimate in 10 of 14 quarters(71%)
ActualEstimate

Forward guidance

Astrana is updating its revenue, net income attributable to Astrana, and EPS - diluted guidance for 2024 while reiterating guidance for Adjusted EBITDA for the year ending December 31, 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

+0.7%

Avg return

Earnings day

-2.1%

Avg return

5 days after

+2.1%

Avg return

30 days after

40%

23 / 57 earnings

Positive

+83.3%

Q3 2011

Best reaction

-40.5%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025+29.4%+22.5%+20.6%
Q3 2025-23.4%-29.4%-33.8%
Q1 2025-11.1%-20.8%-24.5%
Q4 2024-26.8%+5.0%+16.1%
Q3 2024-21.1%-27.9%-30.4%
Q2 2024-1.4%-1.8%+0.1%
Q1 2024-0.7%+1.5%+8.0%
Q4 2023+2.3%+1.8%-1.9%
Q3 2023+9.3%+2.9%+13.4%
Q2 2023+4.2%+3.5%-17.4%
Q1 2023+5.4%+7.0%-0.8%
Q4 2022+6.9%+5.2%+15.2%
Q3 2022+8.4%+8.9%-14.5%
Q2 2022-4.3%-11.0%-29.3%
Q1 2022-0.5%-5.4%-26.4%
Q4 2021-2.0%-11.0%-7.0%
Q3 2021+14.7%+30.5%+0.8%
Q2 2021-11.8%-10.7%-12.9%
Q1 2021+4.5%+4.7%+10.9%
Q4 2020+9.1%+8.8%+8.3%
Q3 2020-1.2%-1.6%+0.5%
Q2 2020+1.8%+2.4%+7.9%
Q1 2020-10.4%-11.6%+13.1%
Q4 2019-12.9%-24.0%+7.0%
Q3 2019-2.9%-0.9%+25.0%
Q2 2019-5.0%+4.8%+31.1%
Q1 2019-1.2%-4.3%-29.7%
Q4 2018-6.4%-8.3%-6.9%
Q3 2018+26.3%+4.0%-4.6%
Q2 2018-13.7%-23.3%-32.2%
Q4 2017+10.8%-6.3%+2.1%
Q1 2018+10.8%-6.3%+2.1%
Q3 2017+3.9%+3.9%+140.0%
Q2 2017+0.0%+0.0%-10.5%
Q1 2017+0.0%+6.7%+36.7%
Q1 2016+4.0%+4.0%+0.0%
Q3 2016-4.8%
Q2 2016-12.9%
Q1 2015-6.5%
Q3 2015-3.2%
Q2 2015+0.0%
Q2 2014+15.6%
Q4 2013
Q3 2013+1.6%
Q2 2013+13.5%
Q1 2013-13.3%
Q4 2012-2.2%
Q3 2012-9.1%
Q2 2012-40.5%
Q1 2012+0.0%
Q4 2011
Q3 2011+83.3%
Q2 2011+0.5%
Q1 2011-0.5%
Q4 2010-3.9%
Q3 2010+19.0%
Q2 2010+0.0%
Q1 2010-2.1%
Q4 2009+9.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro